Acute allograft rejection after lung transplantation: diagnosis and therapy (Q35293934)

7 August 2017

1 reference

title

Acute allograft rejection after lung transplantation: diagnosis and therapy (English)

1 reference

7 August 2017

1 reference

Murali M Chakinala

1

1 reference

PubMed ID

13678311

7 August 2017

Elbert P Trulock

series ordinal

2

1 reference

7 August 2017

1 August 2003

1 reference

Chest surgery clinics of North America

7 August 2017

1 reference

7 August 2017

13

1 reference

7 August 2017

3

1 reference

7 August 2017

525-542

1 reference

Analysis of risk factors for the development of bronchiolitis obliterans syndrome

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Bronchiolitis obliterans organizing pneumonia-like reactions: a nonspecific response or an atypical form of rejection or infection in lung allograft recipients?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

The registry of the international society for heart and lung transplantation: nineteenth official report-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Risk factors for bronchiolitis obliterans: a systematic review of recent publications

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Bronchiolitis obliterans in lung transplant recipients. The "thorn in the side" of lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

1 reference

7 January 2021

The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Prospective study of the value of transbronchial lung biopsy after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Diagnostic yield of bronchoscopies after isolated lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Surveillance bronchoscopy in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

The utility of annual surveillance bronchoscopy in heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Success of lung transplantation without surveillance bronchoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Ten criteria for effective screening: their application to multislice CT screening for pulmonary and colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Management of lung transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

The radiographic appearances of infection and acute rejection of the lung after heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Lung function associated with histologically diagnosed acute lung rejection and pulmonary infection in heart-lung transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Correlation of chest radiographic findings with biopsy-proven acute lung rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

High-resolution computed tomographic findings associated with histologically diagnosed acute lung rejection in heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Acute rejection following lung transplantation: limitations in accuracy of thin-section CT for diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Spirometry values in stable lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

The anatomic distribution of acute cellular rejection in the allograft lung

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Longitudinal profile of bronchoalveolar lavage cell characteristics in patients with a good outcome after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Bronchoalveolar lavage in lung transplantation. State of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart--lung allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Exhaled Nitric Oxide in Human Lung Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Clinical trial of tacrolimus versus cyclosporine in lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Sirolimus rescue therapy for refractory rejection in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Rescue therapy: a role for sirolimus in lung and heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Experiences with leflunomide in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Diagnostic value of follow-up transbronchial lung biopsy after lung rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Acute rejection of lung allografts with various immunosuppressive protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Extracorporeal photochemotherapy: a treatment for organ graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900056-5

7 January 2021

10.1016/S1052-3359(03)00056-5

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

13678311